Sangamo Therapeutics, Inc. logo

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

Overview | Financials
Company Name Sangamo Therapeutics, Inc.
Symbol SGMO
Currency USD
Price 2.87
Market Cap 597,594,270
Dividend Yield 0%
52-week-range 0.29 - 3.175
Industry Biotechnology
Sector Healthcare
CEO Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Website https://www.sangamo.com

An error occurred while fetching data.

About Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used

Related Stocks

The Pennant Group, Inc. logo

The Pennant Group, Inc.

PNTG

33.42 USD

Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc.

FHTX

9.35 USD

Castle Biosciences, Inc. logo

Castle Biosciences, Inc.

CSTL

33.29 USD

Nano-X Imaging Ltd. logo

Nano-X Imaging Ltd.

NNOX

6.1 USD

Intercept Pharmaceuticals, Inc. logo

Intercept Pharmaceuticals, Inc.

ICPT

19 USD

Cullinan Oncology, Inc. logo

Cullinan Oncology, Inc.

CGEM

16.02 USD

Financials

Numbers are in millions USD

Numbers are in millions USD